Zydus Cadila gets USFDA nod to market anti-obesity drug Ruby Khatun Khatun1 July 2017 4:07 PM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Phentermine Hydrochloride orally disintegrating tablets...
Dr Harsh Vardhan launches National Biopharma Mission Ruby Khatun Khatun1 July 2017 4:07 PM ISTNew Delhi: The first ever Industry-Academia mission to accelerate biopharmaceutical development in the country was formally launched by Union Science...
Eris Lifesciences shares gain 1.5% in debut trade Ruby Khatun Khatun30 Jun 2017 11:45 AM ISTNew Delhi: Shares of Eris Lifesciences rose by 1.5 per cent over the issue price of Rs 603 in its debut trade today.The stock listed at Rs 612, up...
New form of Roche's Esbriet approved in Europe for lung disorder Ruby Khatun Khatun30 Jun 2017 11:45 AM ISTRoche said a new Esbriet tablet formulation was approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF), a fatal condition that...
AstraZeneca, Chi-Med take kidney cancer drug into final testing Ruby Khatun Khatun30 Jun 2017 11:45 AM ISTAstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib...
Delhi High Court to hear pharma firms plea on fixed dose drugs ban Ruby Khatun Khatun30 Jun 2017 11:44 AM ISTThe Delhi High Court will today hear the plea filed by several pharmaceutical companies that sought a stay of a central government notification that...
Sales hopes for new Novartis, Merck heart drugs under microscope Ruby Khatun Khatun30 Jun 2017 9:42 AM ISTLondon: Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as...
USFDA gives nod to Zydus Cadila's overactive bladder tablets Ruby Khatun Khatun29 Jun 2017 4:00 PM ISTNew Delhi: The US Food and Drug Administration (USFDA) has given final approval to drug firm Zydus Cadila to market oxybutynin chloride tablets used...
Unichem Laboratories to focus on expansion of product portfolio Ruby Khatun Khatun29 Jun 2017 3:58 PM ISTMumbai: Unichem Laboratories said it will continue to focus on expansion of the product portfolio and increasing market penetration in both domestic...
Sandoz receives approval in Europe for Erelzi to treat multiple inflammatory diseases Ruby Khatun Khatun29 Jun 2017 9:58 AM ISTHolzkirchen: Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced that the European Commission (EC) has approved...
AstraZeneca cancer drug trial prompts investors to take options cover Ruby Khatun Khatun29 Jun 2017 9:58 AM ISTLondon/New York: Investors in drugmaker AstraZeneca have taken defensive positions in the options market ahead of eagerly awaited results of a major...
DoP accepts Sun Pharma's review petition on Fucibet cream 15 gm AI tube while rejecting Histac EVT 2’s AI strip Ruby Khatun Khatun29 Jun 2017 9:57 AM ISTThe Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical's review petition against price fixation of “Fucibet cream 15 gm AI tube” and...
